Your Advocates Ltd’s Henry Schein HSIC Stock Holding History

Your Advocates Ltd’s Portfolio HSIC Stock Details HSIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-150	Closed	-$12.2K	–	325
2023 Q2	$12.2K	Buy	+150	New	+$11.9K	0.01%	121

Other funds holding HSIC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Your Advocates Ltd's HSIC Position: Q3 2023 in Review

Your Advocates Ltd sold out of Henry Schein (HSIC) in Q3 2023, closing a stake of 150 shares — an estimated $12.2K sold.

Your Advocates Ltd first reported a position in HSIC in Q2 2023 and held it in 1 quarter. The position peaked at $12.2K in Q2 2023. 555 funds tracked by Wall St. Rank hold HSIC as of Q3 2023.

Your Advocates Ltd reported no remaining Henry Schein position as of Q3 2023 after selling out during the quarter.
Your Advocates Ltd sold 150 Henry Schein shares in Q3 2023, an estimated $12.2K.
Your Advocates Ltd first reported a position in Henry Schein in Q2 2023 and held it in 1 quarter.
Your Advocates Ltd's Henry Schein position peaked at $12.2K in Q2 2023.
555 funds tracked by Wall St. Rank held Henry Schein as of Q3 2023.

Based on Your Advocates Ltd's 13F filing for Q3 2023, filed 2 Nov 2023.